These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27542553)

  • 41. Somatoform disorders and medically unexplained symptoms in primary care.
    Haller H; Cramer H; Lauche R; Dobos G
    Dtsch Arztebl Int; 2015 Apr; 112(16):279-87. PubMed ID: 25939319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioural and psychological management of somatic symptom disorders: an overview.
    Sharma MP; Manjula M
    Int Rev Psychiatry; 2013 Feb; 25(1):116-24. PubMed ID: 23383673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical profile of pediatric somatoform disorders.
    Bisht J; Sankhyan N; Kaushal RK; Sharma RC; Grover N
    Indian Pediatr; 2008 Feb; 45(2):111-5. PubMed ID: 18310789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of DSM-5 somatic symptom disorder in Chinese patients with breast cancer.
    Li J; Fritzsche K; Glinka M; Pang Y; Song L; Wang Y; Li Z; He Y; Zhang Y; He S; Leonhart R; Toussaint AK; Tang L
    Psychooncology; 2022 Aug; 31(8):1302-1312. PubMed ID: 35353396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stability of somatoform symptoms--implications for classification.
    Rief W; Rojas G
    Psychosom Med; 2007 Dec; 69(9):864-9. PubMed ID: 18040096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistence rate of DSM-5 somatic symptom disorder: 4-year follow-up in patients from a psychosomatic outpatient clinic.
    Behm AC; Hüsing P; Löwe B; Toussaint A
    Compr Psychiatry; 2021 Oct; 110():152265. PubMed ID: 34311179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An experimental paradigm to repeatedly induce somatic symptoms.
    Schwarz J; Gottschalk JM; Ruckmann J; Rief W; Kleinstäuber M
    J Psychosom Res; 2016 Mar; 82():24-30. PubMed ID: 26944395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis.
    Löwe B; Levenson J; Depping M; Hüsing P; Kohlmann S; Lehmann M; Shedden-Mora M; Toussaint A; Uhlenbusch N; Weigel A
    Psychol Med; 2022 Mar; 52(4):632-648. PubMed ID: 34776017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The health preoccupation diagnostic interview: inter-rater reliability of a structured interview for diagnostic assessment of DSM-5 somatic symptom disorder and illness anxiety disorder.
    Axelsson E; Andersson E; Ljótsson B; Wallhed Finn D; Hedman E
    Cogn Behav Ther; 2016 Jun; 45(4):259-69. PubMed ID: 27096407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Descriptive and predictive validity of somatic attributions in patients with somatoform disorders: a systematic review of quantitative research.
    Douzenis A; Seretis D
    J Psychosom Res; 2013 Sep; 75(3):199-210. PubMed ID: 23972408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of somatic symptom disorder.
    Henningsen P
    Dialogues Clin Neurosci; 2018 Mar; 20(1):23-31. PubMed ID: 29946208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The 2-year course of Medically Unexplained Physical Symptoms (MUPS) in terms of symptom severity and functional status: results of the PROSPECTS cohort study.
    Claassen-van Dessel N; van der Wouden JC; Hoekstra T; Dekker J; van der Horst HE
    J Psychosom Res; 2018 Jan; 104():76-87. PubMed ID: 29275789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medically unexplained physical symptoms in patients attending a medical outpatient clinic in a tertiary hospital in North India.
    Sharma M; Singh SM; Avasthi A; Varma SC; Sharma A; Suri V
    Asian J Psychiatr; 2018 Feb; 32():99-104. PubMed ID: 29222988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Social Stigma Towards People with Medically Unexplained Symptoms: the Somatic Symptom Disorder.
    Eger Aydogmus M
    Psychiatr Q; 2020 Jun; 91(2):349-361. PubMed ID: 31898214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality of life in primary care patients with moderate medically unexplained physical symptoms.
    van Westrienen PE; Pisters MF; Toonders SAJ; Gerrits M; de Wit NJ; Veenhof C
    Qual Life Res; 2020 Mar; 29(3):693-703. PubMed ID: 31732910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychological and interactional characteristics of patients with somatoform disorders: Validation of the Somatic Symptoms Experiences Questionnaire (SSEQ) in a clinical psychosomatic population.
    Herzog A; Voigt K; Meyer B; Wollburg E; Weinmann N; Langs G; Löwe B
    J Psychosom Res; 2015 Jun; 78(6):553-62. PubMed ID: 25840951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Somatoform disorders in DSM-IV: mental or physical disorders?
    Sykes R
    J Psychosom Res; 2006 Apr; 60(4):341-4. PubMed ID: 16581355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Demographic and health-related factors associated with reduced work functioning in people with moderate medically unexplained physical symptoms: a cross-sectional study.
    van Tilburg ML; van Westrienen PE; Pisters MF
    BMC Public Health; 2020 Aug; 20(1):1316. PubMed ID: 32867731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construct validity and descriptive validity of somatoform disorders in light of proposed changes for the DSM-5.
    Wollburg E; Voigt K; Braukhaus C; Herzog A; Löwe B
    J Psychosom Res; 2013 Jan; 74(1):18-24. PubMed ID: 23272984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Somatoform pain disorder in the general population.
    Grabe HJ; Meyer C; Hapke U; Rumpf HJ; Freyberger HJ; Dilling H; John U
    Psychother Psychosom; 2003; 72(2):88-94. PubMed ID: 12601226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.